Kayne Anderson Rudnick Investment Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
AC
SCM
Kayne Anderson Rudnick Investment Management's BLUE Position: Q1 2021 in Review
Kayne Anderson Rudnick Investment Management sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 1 share — an estimated $1K sold.
Kayne Anderson Rudnick Investment Management first reported a position in BLUE in Q1 2018 and held it in 9 quarters. The position peaked at $14.5M in Q1 2018. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.
- Kayne Anderson Rudnick Investment Management reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
- Kayne Anderson Rudnick Investment Management sold 1 bluebird bio share in Q1 2021, an estimated $1K.
- Kayne Anderson Rudnick Investment Management first reported a position in bluebird bio in Q1 2018 and held it in 9 quarters.
- Kayne Anderson Rudnick Investment Management's bluebird bio position peaked at $14.5M in Q1 2018.
- 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.
Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2021, filed 17 May 2021.